These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27813537)
1. Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward. Prasad V; Rajkumar SV Blood Cancer J; 2016 Nov; 6(11):e489. PubMed ID: 27813537 [No Abstract] [Full Text] [Related]
3. The changing roles of industry and academia. Bauer EA; Cohen DE J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271 [TBL] [Abstract][Full Text] [Related]
4. Financial conflicts of interest in biomedical research: the need to improve the system. Wang AT; Montori VM; Murad MH Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455 [TBL] [Abstract][Full Text] [Related]
5. Can a good tree bring forth evil fruit? The funding of medical research by industry. Capps B Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955 [TBL] [Abstract][Full Text] [Related]
7. Is smaller better? Wallner PE J Am Coll Radiol; 2004 Dec; 1(12):904-5. PubMed ID: 17411730 [No Abstract] [Full Text] [Related]
8. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
10. Texas cancer fund seeks fresh start. Baker M Nature; 2012 Oct; 490(7421):459-60. PubMed ID: 23099380 [No Abstract] [Full Text] [Related]
11. Is there a crisis of accountability in the American research university? Smith BL; Korn D Minerva; 2000; 38(2):129-45. PubMed ID: 17152687 [No Abstract] [Full Text] [Related]
12. [Conflict of interest in clinical research--trends in guidelines for research ethics in Japan and other countries]. Tashiro M Seishin Shinkeigaku Zasshi; 2010; 112(11):1130-5. PubMed ID: 21351693 [No Abstract] [Full Text] [Related]
13. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology. Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081 [TBL] [Abstract][Full Text] [Related]
14. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
15. Industry and medicine: conflicting interests and the power of money. Popovsky MA; Garcia N Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103 [No Abstract] [Full Text] [Related]
16. Editorial policies on financial disclosure. Jacobson MF; Sharpe VA; Angell M; Ashford NA; Blum A; Chary LK; Cho M; Coull BC; Davis D; Doolittle RF; Egilman D; Epstein SS; Greenberg M; Hooper K; Huff J; Joshi TK; Krimsky S; LaDou J; Levenstein C; Miles S; Needleman H; Pellegrino ED; Ravanesi B; Sass J; Schecter A; Schneiderman JS; Schubert D; Soffritti M; Suzuki D; Takaro TK; Temple NJ; Terracini B; Thompson A; Wallinga D; Wing S Nat Neurosci; 2003 Oct; 6(10):1001. PubMed ID: 14513030 [No Abstract] [Full Text] [Related]